What Drives Drug Pricing?

High drug prices have seized headlines, angered patient advocates, and prompted congressional hearings. Many causes have been suggested — among them, a fragmented pharmaceutical market that limits competition, the quest for profits (whether to fund expensive R&D or otherwise), and government regulations that bar Medicare from negotiating prices. Harder to find are solutions for patients who cannot afford their therapies. Venture capitalists may be a unique leverage point on the system because their investments can encourage risk-taking and the development of novel, high-impact medicines, shifting the locus of industry’s search for rewards. How do we encourage a drug-development system that innovates, while keeping lifesaving therapies affordable?

Festival: Spotlight Health 2017

More on this Session

Watch and Listen: Policy

Despite repeated attempts, Congress has not repealed the Affordable Care Act, although the Trump Administration has... See more
A healthy community is characterized not only by the absence of illness but by attributes that promote well-being and... See more
Who is responsible for keeping us healthy? Provocative questions about responsibility, control, and power are being... See more
The Veterans Health Administration, which serves nine million vets, has come under fire for long delays in providing... See more
Federal funds could not be used to pay for sugar-sweetened beverages under the Supplemental Nutrition Assistance... See more
Gun violence in the US is a public health epidemic. With partisan battles currently making state and federal... See more